Literature DB >> 17558276

Role of ventral striatum in reward-based decision making.

Hauke R Heekeren1, Isabell Wartenburger, Alexander Marschner, Thomas Mell, Arno Villringer, Friedel M Reischies.   

Abstract

So far, the specific role of the ventral striatum in reward-based decision making remains elusive. Here, we examined the role of the ventral striatum in reward-based decision making using functional MRI and a probabilistic object reversal task. During decision making, activity in the ventral striatum increased monotonically as a function of association learning and was greatest when the individuals expected to be rewarded for the decision with high certainty. Conversely, during the reward phase, activity in the ventral striatum showed an inverted U-shaped modulation by learning and was greatest when uncertainty about the outcome was maximal. Our data indicate that, during reward-based decision making, the ventral striatal signal dynamically changes over time dependent on the phase of the reward process and on the learning status and thereby acts as a motivational engine for the continuation of behavior.

Mesh:

Substances:

Year:  2007        PMID: 17558276     DOI: 10.1097/WNR.0b013e3281532bd7

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  22 in total

Review 1.  From movement to thought: executive function, embodied cognition, and the cerebellum.

Authors:  Leonard F Koziol; Deborah Ely Budding; Dana Chidekel
Journal:  Cerebellum       Date:  2012-06       Impact factor: 3.847

Review 2.  Adaptation, expertise, and giftedness: towards an understanding of cortical, subcortical, and cerebellar network contributions.

Authors:  Leonard F Koziol; Deborah Ely Budding; Dana Chidekel
Journal:  Cerebellum       Date:  2010-12       Impact factor: 3.847

Review 3.  Common and distinct networks underlying reward valence and processing stages: a meta-analysis of functional neuroimaging studies.

Authors:  Xun Liu; Jacqueline Hairston; Madeleine Schrier; Jin Fan
Journal:  Neurosci Biobehav Rev       Date:  2010-12-24       Impact factor: 8.989

Review 4.  Dopamine overdose hypothesis: evidence and clinical implications.

Authors:  David E Vaillancourt; Daniel Schonfeld; Youngbin Kwak; Nicolaas I Bohnen; Rachael Seidler
Journal:  Mov Disord       Date:  2013-10-09       Impact factor: 10.338

5.  Insular neural system controls decision-making in healthy and methamphetamine-treated rats.

Authors:  Hiroyuki Mizoguchi; Kentaro Katahira; Ayumu Inutsuka; Kazuya Fukumoto; Akihiro Nakamura; Tian Wang; Taku Nagai; Jun Sato; Makoto Sawada; Hideki Ohira; Akihiro Yamanaka; Kiyofumi Yamada
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-06       Impact factor: 11.205

6.  Genetic variation in dopaminergic neuromodulation influences the ability to rapidly and flexibly adapt decisions.

Authors:  Lea K Krugel; Guido Biele; Peter N C Mohr; Shu-Chen Li; Hauke R Heekeren
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-12       Impact factor: 11.205

7.  Spontaneous activity in medial orbitofrontal cortex correlates with trait anxiety in healthy male adults.

Authors:  Shao-Wei Xue; Tien-Wen Lee; Yong-Hu Guo
Journal:  J Zhejiang Univ Sci B       Date:  2018 Aug.       Impact factor: 3.066

8.  Striatal sensitivity to reward deliveries and omissions in substance dependent patients.

Authors:  James M Bjork; Ashley R Smith; Daniel W Hommer
Journal:  Neuroimage       Date:  2008-07-11       Impact factor: 6.556

9.  Differential influence of levodopa on reward-based learning in Parkinson's disease.

Authors:  Susanne Graef; Guido Biele; Lea K Krugel; Frank Marzinzik; Michael Wahl; Johann Wotka; Fabian Klostermann; Hauke R Heekeren
Journal:  Front Hum Neurosci       Date:  2010-10-14       Impact factor: 3.169

10.  Altered function of ventral striatum during reward-based decision making in old age.

Authors:  Thomas Mell; Isabell Wartenburger; Alexander Marschner; Arno Villringer; Friedel M Reischies; Hauke R Heekeren
Journal:  Front Hum Neurosci       Date:  2009-10-30       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.